HAIRY CELL LEUKEMIA
Clinical trials for HAIRY CELL LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new HAIRY CELL LEUKEMIA trials appear
Sign up with your email to follow new studies for HAIRY CELL LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Targeted drug shows promise against rare leukemia in small trial
Disease control CompletedThis study tested the drug vemurafenib in 36 people with hairy cell leukemia that had returned or not responded to standard treatments. The goal was to see how well the drug could clear leukemia cells from the blood and what side effects it might cause. Participants took vemurafe…
Matched conditions: HAIRY CELL LEUKEMIA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 26, 2026 09:20 UTC
-
New combo offers gentler option for rare leukemia
Disease control CompletedThis study tested a combination of two drugs, vemurafenib (taken by mouth) and rituximab (given through a vein), for people with hairy cell leukemia. The goal was to see if this treatment works as well as or better than standard chemotherapy, but with fewer side effects. The stud…
Matched conditions: HAIRY CELL LEUKEMIA
Phase: PHASE2 • Sponsor: Scripps Health • Aim: Disease control
Last updated May 26, 2026 08:59 UTC
-
New drug combo shows promise for Hard-to-Treat blood cancers
Disease control CompletedThis study tested a combination of two drugs, acalabrutinib and pembrolizumab, in 161 people with different types of blood cancers like lymphoma and leukemia. The main goal was to check safety and see how well the drugs worked together. Researchers measured side effects and tumor…
Matched conditions: HAIRY CELL LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: Acerta Pharma BV • Aim: Disease control
Last updated May 22, 2026 13:53 UTC